A Susceptible Mouse Model for Zika Virus Infection

PLoS Neglected Tropical Diseases

Volumn 10, Issue 5, 2016, Pages

  Dowall, Stuart D ^a   Graham, Victoria A ^a   Rayner, Emma ^a   Atkinson, Barry ^a   Hall, Graham ^a   Watson, Robert J ^a   Bosworth, Andrew ^a   Bonney, Laura C ^a   Kitchen, Samantha ^a   Hewson, Roger ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BETA INTERFERON RECEPTOR; VIRUS RNA; IFNAR1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FLAVIVIRIDAE; FLAVIVIRIDAE INFECTION; HEMATOPOIESIS; HISTOLOGY; LIMIT OF DETECTION; MEGAKARYOCYTE; MOUSE; MOUSE MODEL; NONHUMAN; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; SURVIVAL RATE; VIRUS ISOLATION; VIRUS LOAD; VIRUS VIRULENCE; ZIKA VIRUS; ANIMAL; BRAIN; CLASSIFICATION; DEFICIENCY; DISEASE MODEL; DISEASE PREDISPOSITION; FEMALE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; PATHOGENICITY; VIROLOGY; ZIKA FEVER;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; FEMALE; MICE; MICE, KNOCKOUT; RECEPTOR, INTERFERON ALPHA-BETA; RNA, VIRAL; ZIKA VIRUS; ZIKA VIRUS INFECTION;

EID: 84971641427     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0004658     Document Type: Article

References (62)

1. Dick G.W., Kitchen S.F., Haddow A.J., Zika virus. I. Isolations and serological specificity. Trans R Soc Trop Med Hyg, 1952. 46(5): p. 509–20. 12995440
2. Fagbami A.H., Zika virus infections in Nigeria: virological and seroepidemiological investigations in Oyo State. J Hyg (Lond), 1979. 83(2): p. 213–9.
3. Darwish M.A., et al., A sero-epidemiological survey for certain arboviruses (Togaviridae) in Pakistan. Trans R Soc Trop Med Hyg, 1983. 77(4): p. 442–5. 6314612
4. Marchette N.J., Garcia R., Rudnick A., Isolation of Zika virus from Aedes aegypti mosquitoes in Malaysia. Am J Trop Med Hyg, 1969. 18(3): p. 411–5. 4976739
5. Olson J.G., et al., Zika virus, a cause of fever in Central Java, Indonesia. Trans R Soc Trop Med Hyg, 1981. 75(3): p. 389–93. 6275577
6. Duffy M.R., et al., Zika virus outbreak on Yap Island, Federated States of Micronesia. N Engl J Med, 2009. 360(24): p. 2536–43. doi: 10.1056/NEJMoa080571519516034
7. Cao-Lormeau V.M., et al., Zika virus, French polynesia, South pacific, 2013. Emerg Infect Dis, 2014. 20(6): p. 1085–6. doi: 10.3201/eid2006.14013824856001
8. (ECDC), E.C.f.D.p.a.C. Rapid risk assessment: Zika virus infection outbreak, French Polynesia. 2014 [cited 2016; Available from: http://ecdc.europa.eu/en/publications/Publications/Zika-virus-French-Polynesia-rapid-risk-assessment.pdf.
9. Musso D., Nilles E.J., Cao-Lormeau V.M., Rapid spread of emerging Zika virus in the Pacific area. Clin Microbiol Infect, 2014. 20(10): p. O595–6. doi: 10.1111/1469-0691.1270724909208
10. Atkinson, B., et al., Detection of Zika virus RNA in seminal fluid two months post onset of symptoms. Emerg Infect Dis, 2016.
11. Campos G.S., Bandeira A.C., Sardi S.I., Zika Virus Outbreak, Bahia, Brazil. Emerg Infect Dis, 2015. 21(10): p. 1885–6. doi: 10.3201/eid2110.15084726401719
12. Salvador F.S., Fujita D.M., Entry routes for Zika virus in Brazil after 2014 world cup: New possibilities. Travel Med Infect Dis, 2015.
13. Musso D., Zika Virus Transmission from French Polynesia to Brazil. Emerg Infect Dis, 2015. 21(10): p. 1887.
14. Zanluca C., et al., First report of autochthonous transmission of Zika virus in Brazil. Mem Inst Oswaldo Cruz, 2015. 110(4): p. 569–72. doi: 10.1590/0074-0276015019226061233
15. Musso D., Cao-Lormeau V.M., Gubler D.J., Zika virus: following the path of dengue and chikungunya?Lancet, 2015. 386(9990): p. 243–4. doi: 10.1016/S0140-6736(15)61273-926194519
16. Bogoch II, et al., Anticipating the international spread of Zika virus from Brazil. Lancet, 2016.
17. McCarthy M., First US case of Zika virus infection is identified in Texas. BMJ, 2016. 352: p. i212. doi: 10.1136/bmj.i21226762624
18. WHO. Briefing on Zika virus. 2016; Available from: http://www.who.int/emergencies/zika-virus/en/.
19. Israeli E., et al., Guillain-Barre syndrome—a classical autoimmune disease triggered by infection or vaccination. Clin Rev Allergy Immunol, 2012. 42(2): p. 121–30. doi: 10.1007/s12016-010-8213-320890797
20. Hughes R.A., Cornblath D.R., Guillain-Barre syndrome. Lancet, 2005. 366(9497): p. 1653–66. 16271648
21. Oehler E., et al., Zika virus infection complicated by Guillain-Barre syndrome—case report, French Polynesia, December 2013. Euro Surveill, 2014. 19(9).
22. Sejvar J.J., et al., Population incidence of Guillain-Barre syndrome: a systematic review and meta-analysis. Neuroepidemiology, 2011. 36(2): p. 123–33. doi: 10.1159/00032471021422765
23. Dyer O., Zika virus spreads across Americas as concerns mount over birth defects. BMJ, 2015. 351: p. h6983. doi: 10.1136/bmj.h698326698165
24. Adams Waldorf K.M., McAdams R.M., Influence of infection during pregnancy on fetal development. Reproduction, 2013. 146(5): p. R151–62. doi: 10.1530/REP-13-023223884862
25. Centers for Disease, C. and PreventionIntrauterine West Nile virus infection—New York, 2002. MMWR Morb Mortal Wkly Rep, 2002. 51(50): p. 1135–6. 12537289
26. O'Leary D.R., et al., Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003–2004. Pediatrics, 2006. 117(3): p. e537–45. 16510632
27. Inomata K., et al., A case of suspected congenital rubella encephalopathy. Brain Dev, 1980. 2(4): p. 401–5. 7224096
28. Gabrielli L., et al., Congenital cytomegalovirus infection: patterns of fetal brain damage. Clin Microbiol Infect, 2012. 18(10): p. E419–27. doi: 10.1111/j.1469-0691.2012.03983.x22882294
29. Milatovic D., et al., Herpes simplex virus type 1 encephalitis is associated with elevated levels of F2-isoprostanes and F4-neuroprostanes. J Neurovirol, 2002. 8(4): p. 295–305. 12161814
30. Nagel M.A., Gilden D., Developments in Varicella Zoster Virus Vasculopathy. Curr Neurol Neurosci Rep, 2016. 16(2): p. 12. doi: 10.1007/s11910-015-0614-526750127
31. Cohen S., et al., Cerebral injury in perinatally HIV-infected children compared to matched healthy controls. Neurology, 2016. 86(1): p. 19–27. doi: 10.1212/WNL.000000000000220926561287
32. Bonthius D.J., Lymphocytic choriomeningitis virus: an underrecognized cause of neurologic disease in the fetus, child, and adult. Semin Pediatr Neurol, 2012. 19(3): p. 89–95. doi: 10.1016/j.spen.2012.02.00222889536
33. Jayasundara V.K., Pathiratne A., Effect of repeated application of fenthion as a mosquito larvicide on Nile tilapia (Oreochromis niloticus) inhabiting selected water canals in Sri Lanka. Bull Environ Contam Toxicol, 2008. 80(4): p. 374–7. doi: 10.1007/s00128-008-9392-y18344014
34. Waggoner J.J., Pinsky B.A., Zika Virus: Diagnostics for an Emerging Pandemic Threat. J Clin Microbiol, 2016.
35. Tetro J.A., Zika and microcephaly: Causation, correlation, or coincidence?Microbes Infect, 2016.
36. Bell T.M., Field E.J., Narang H.K., Zika virus infection of the central nervous system of mice. Arch Gesamte Virusforsch, 1971. 35(2): p. 183–93. 5002906
37. Dick G.W., Zika virus. II. Pathogenicity and physical properties. Trans R Soc Trop Med Hyg, 1952. 46(5): p. 521–34. 12995441
38. Weinbren M.P., Williams M.C., Zika virus: further isolations in the Zika area, and some studies on the strains isolated. Trans R Soc Trop Med Hyg, 1958. 52(3): p. 263–8. 13556872
39. McCrae A.W., Kirya B.G., Yellow fever and Zika virus epizootics and enzootics in Uganda. Trans R Soc Trop Med Hyg, 1982. 76(4): p. 552–62. 6304948
40. Haddow A.J., et al., Twelve Isolations of Zika Virus from Aedes (Stegomyia) Africanus (Theobald) Taken in and above a Uganda Forest. Bull World Health Organ, 1964. 31: p. 57–69. 14230895
41. Bearcroft W.G., Zika virus infection experimentally induced in a human volunteer. Trans R Soc Trop Med Hyg, 1956. 50(5): p. 442–8. 13380987
42. Way J.H., Bowen E.T., Platt G.S., Comparative studies of some African arboviruses in cell culture and in mice. J Gen Virol, 1976. 30(1): p. 123–30. 1245842
43. Macnamara F.N., Zika virus: a report on three cases of human infection during an epidemic of jaundice in Nigeria. Trans R Soc Trop Med Hyg, 1954. 48(2): p. 139–45. 13157159
44. Reagan R.L., Chang S.C., Brueckner A.L., Electron micrographs of erythrocytes from Swiss albino mice infected with Zika virus. Tex Rep Biol Med, 1955. 13(4): p. 934–8. 13281796
45. Lanciotti R.S., et al., Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis, 2008. 14(8): p. 1232–9. doi: 10.3201/eid1408.08028718680646
46. Ponnudurai T., et al., Feeding behaviour and sporozoite ejection by infected Anopheles stephensi. Trans R Soc Trop Med Hyg, 1991. 85(2): p. 175–80. 1887464
47. Styer L.M., et al., Mosquitoes inoculate high doses of West Nile virus as they probe and feed on live hosts. PLoS Pathog, 2007. 3(9): p. 1262–70. 17941708
48. Simpson D.I., Zika Virus Infection in Man. Trans R Soc Trop Med Hyg, 1964. 58: p. 335–8. 14175744
49. Bereczky S., et al., Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J Gen Virol, 2010. 91(Pt 6): p. 1473–7. doi: 10.1099/vir.0.019034-020164263
50. Dowall S.D., et al., Hazara virus infection is lethal for adult type I interferon receptor-knockout mice and may act as a surrogate for infection with the human-pathogenic Crimean-Congo hemorrhagic fever virus. J Gen Virol, 2012. 93(Pt 3): p. 560–4. doi: 10.1099/vir.0.038455-022090213
51. Partidos C.D., et al., Cross-protective immunity against o'nyong-nyong virus afforded by a novel recombinant chikungunya vaccine. Vaccine, 2012. 30(31): p. 4638–43. doi: 10.1016/j.vaccine.2012.04.09922583812
52. Seymour R.L., et al., The role of innate versus adaptive immune responses in a mouse model of O'nyong-nyong virus infection. Am J Trop Med Hyg, 2013. 88(6): p. 1170–9. doi: 10.4269/ajtmh.12-067423568285
53. Aoki K., et al., Type-I interferon response affects an inoculation dose-independent mortality in mice following Japanese encephalitis virus infection. Virol J, 2014. 11: p. 105. doi: 10.1186/1743-422X-11-10524903089
54. Buttigieg K.R., et al., A novel vaccine against Crimean-Congo Haemorrhagic Fever protects 100% of animals against lethal challenge in a mouse model. PLoS One, 2014. 9(3): p. e91516. doi: 10.1371/journal.pone.009151624621656
55. Holzer G.W., et al., Evaluation of an inactivated Ross River virus vaccine in active and passive mouse immunization models and establishment of a correlate of protection. Vaccine, 2011. 29(24): p. 4132–41. doi: 10.1016/j.vaccine.2011.03.08921477673
56. Plante K.S., et al., Extended Preclinical Safety, Efficacy and Stability Testing of a Live-attenuated Chikungunya Vaccine Candidate. PLoS Negl Trop Dis, 2015. 9(9): p. e0004007. doi: 10.1371/journal.pntd.000400726340754
57. Muller U., et al., Functional role of type I and type II interferons in antiviral defense. Science, 1994. 264(5167): p. 1918–21. 8009221
58. Oliveira Melo A.S., et al., Zika virus intrauterine infection causes fetal brain abnormality and microcephaly: tip of the iceberg?Ultrasound Obstet Gynecol, 2016. 47(1): p. 6–7. doi: 10.1002/uog.1583126731034
59. Mlakar J., et al., Zika Virus Associated with Microcephaly. N Engl J Med, 2016.
60. Ventura C.V., et al., Zika virus in Brazil and macular atrophy in a child with microcephaly. Lancet, 2016.
61. Gourinat A.C., et al., Detection of Zika virus in urine. Emerg Infect Dis, 2015. 21(1): p. 84–6. doi: 10.3201/eid2101.14089425530324
62. Christofferson R.C., Zika Virus Emergence and Expansion: Lessons Learned from Dengue and Chikungunya May Not Provide All the Answers. Am J Trop Med Hyg, 2016.